Skip to main content

Consumer

By Emily Olsen | 12:56 pm | January 19, 2022
The study, sponsored by digital musculoskeletal-care company SWORD Health, also found improvements in secondary measures like surgery intent and painkiller use.
By Emily Olsen | 12:51 pm | January 18, 2022
The male and female hormone tests are the first product in the company's Kind at Home consumer products division.
By Laura Lovett | 03:46 pm | January 14, 2022
The company is now offering a topical Finasteride and Minoxidil spray as well as oral spironolactone through its virtual care platform. 
By Tammy Lovell | 11:55 am | January 13, 2022
Also, Tech accelerator calls for gut health startups in the EMEA region
By Emily Olsen | 12:46 pm | January 10, 2022
The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.
By Laura Lovett | 12:33 pm | January 10, 2022
Users can tap into the system to measure their blood pressure, heart rate, heart variability rate and more. 
By Laura Lovett | 05:45 pm | January 07, 2022
MobiHealthNews rounds up all of the new digital health technologies released at CES this year. 
By Emily Olsen | 04:37 pm | January 07, 2022
The growth of telehealth and remote-monitoring tools could be a game-changer for women's health, particularly maternal and fetal care.
By Emily Olsen | 12:24 pm | January 07, 2022
During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.
By Laura Lovett | 04:13 pm | January 06, 2022
The company is selling the devices for $2,950.